Cargando…
TWIST1-EP300 Expedites Gastric Cancer Cell Resistance to Apatinib by Activating the Expression of COL1A2
The association between collagen type I alpha (COL1A) and chemoresistance has been verified in cancers. However, the specific role of COL1A2 in gastric cancer (GC) cell resistance to apatinib, a highly selective small-molecule inhibitor of vascular endothelial growth factor receptor 2, has not been...
Autores principales: | Yu, Gang, Chen, Wanjing, Li, Xianghua, Yu, Liang, Xu, Yanyan, Ruan, Qiang, He, Yawei, Wang, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8888114/ https://www.ncbi.nlm.nih.gov/pubmed/35242497 http://dx.doi.org/10.1155/2022/5374262 |
Ejemplares similares
-
Experimental analysis of bladder cancer-associated mutations in EP300 identifies EP300-R1627W as a driver mutation
por: Luo, Mayao, et al.
Publicado: (2023) -
Apatinib combined with S-1 as second-line therapy in advanced gastric cancer
por: Qiu, Zhi-Yuan, et al.
Publicado: (2021) -
Identification of COL1A1 and COL1A2 as candidate prognostic factors in gastric cancer
por: Li, Jun, et al.
Publicado: (2016) -
Differential Expression of COL1A1, COL1A2, COL6A3, and SULF1 as Prognostic Biomarkers in Gastric Cancer
por: Hu, Yan, et al.
Publicado: (2021) -
Downregulation of COL12A1 and COL13A1 by a selective EP2 receptor agonist, omidenepag, in human trabecular meshwork cells
por: Kumon, Masashi, et al.
Publicado: (2023)